SEC Form 4 · accession 0000105770-26-000085
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Brutschea Haugen
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 7:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,113 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitF2 | — | Jun 30, 2026 | A | 46 | A | — | — | Common Stock | 46 | 307 | D |
Explanation of responses
- F1Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.